IngredientsPullulanase is a starch debranching enzyme having pullulan 6-glucano-hydrolase activity, classified as EC 3.2.1.41, that catalyzes the hydrolysis of α-1,6-glycosidic bonds in pullulan, releasing maltotriose with reducing carbohydrate ends. Its systematic name is pullulan 6-α-glucanohydrolase, and it is also commonly referred to as a debranching enzyme, limit dextrinase, and R-enzyme (in plant biology contexts). According to their peptide sequences and substrate specificities, debranching enzymes can be categorized into two major types: isoamylase (EC 3.2.1.68, ISA) and pullulanase (PUL, limit dextrinase, R-enzyme, EC 3.2.1.41).
According to the differences in protein structure and the classification basis of the Glycoside Hydrolase (GH) family, pullulanase can be classified into two different glycoside hydrolase protein families: GH13 and GH57. Most pullulanases belong to the GH13 family, and only a few belong to the GH57 family. Pullulanase (EC 3.2.1.41, PUL), a debranching enzyme belonging to glycoside hydrolase family 13 subfamily 13, catalyses the cleavage of α-1,6 linkages of pullulan and β-limit dextrin.
In terms of spatial structure, the GH13 family of pullulanase has the typical (α/β)₈ barrel structure characteristic of that family, while the GH57 family has a (α/β)₇ barrel structure. Pullulanases consist of multiple distinct domains, including a catalytic domain belonging to the glycoside hydrolase (GH) family 13 and carbohydrate-binding modules (CBM), including CBM41.
To date, five groups of pullulanase enzymes have been reported: (i) pullulanase type I, (ii) amylopullulanase, (iii) neopullulanase, (iv) isopullulanase, and (v) pullulan hydrolase type III.
Although both isoamylase and pullulanase can act on α-1,6 glucosidic linkages, only pullulanase shows high specific activity against pullulan, α-1,6-linked maltotriose units, and liberates maltotriose as the final product.
Pullulan is a polysaccharide in which α-1,4-linked maltotriosyl units are combined via an α-1,6 linkage. Pullulan is a water-soluble glucan gum produced aerobically by the yeast-like fungus Aureobasidium pullulans. Pullulanase acts specifically on the α-1,6 linkages joining these maltotriose units, liberating them as free maltotriose molecules.
Pullulanase was first isolated from Klebsiella pneumoniae by Bender and Wallenfels. These enzymes are distributed among a variety of plants, animals, and microbes. Many microorganisms, including mesophiles, thermophiles, and hyperthermophiles, have been identified as efficient pullulanase producers.
Type I pullulanase was first discovered in a mesophilic bacterium called Aerobacter aerogenes (now known as Klebsiella aerogenes; the human pathogen K. pneumoniae belongs to the same genus). Type I pullulanases were subsequently found to be widely distributed in various microorganisms, including Bacillus acidopullulyticus, B. flavocaldarius, K. pneumoniae, Fervidobacterium pennavorans, and Anoxybacillus LM18-11.
Among bacteria relevant to food-grade production, the pullulanase may be a bacterial pullulanase, preferably derived from a strain of the genus Bacillus, especially derived from a strain of Bacillus deramificans, Bacillus subtilis, Bacillus amyloderamificans, or Bacillus acidopullulyticus. Among bacterial strains, Anoxybacillus sp., Bacillus pseudofirmus, Bacillus naganoensis, Paenibacillus barengoltzii, Bacillus acidopullulyticus, B. cereus, B. flavothermus, B. deramificans, Klebsiella variicola, and Thermotoga neapolitana, among others, have been reported as potent pullulanase producers.
Among the several amylolytic enzymes produced by the hyperthermophilic archaeon Pyrococcus furiosus, pullulanase was characterised by a temperature optimum of at least 100°C and a high degree of thermostability. The pullulanase from P. furiosus was purified and reported to be a glycoprotein with an optimum of activity at 100°C. Pullulanase has been discovered and identified from various microorganisms, such as mesophilic Bacillus sp. strain S-1, thermophiles B. thermoleovorans US105, and hyperthermophiles Rhodothermus marinus.
Debranching enzymes are required for both starch synthesis and degradation in plants. Generally, plants contain three isoforms of isoamylase (ISA1, ISA2, and ISA3) but only one pullulanase. Research has studied pullulanase from cassava (Manihot esculenta Crantz) tubers, an important economic crop. Pullulanase activity has also been documented in cereal grains and other starchy plant tissues where it participates in starch catabolism.
Commercial pullulanase preparations are produced through submerged microbial fermentation. The enzyme is available in liquid and dry/powdered form, and can be used in free or immobilized configurations. Pullulanase is an industrially important enzyme, which is generally used in combination with other amylolytic enzymes (α-amylase, β-amylase, glucoamylase) in the starch processing industry for the production of sugar syrups. For food applications, the pullulanase can be immobilized on a support.
The history of pullulanase begins with the characterization of its substrate. Bernier was the first to isolate pullulan from the fungus A. pullulans and to determine its chemical structure between 1950 and 1958. The name "pullulan" was given by a scientist called Bender in 1960 (Bender, Lehmann, & Wallenfels, 1959).
The discovery of an extracellular enzyme from Aerobacter aerogenes, i.e., pullulanase, proved to be a critical tool for the analysis of pullulan structure (Bender & Wallenfels, 1961). In the 1960s, pullulan structure was resolved (Bender & Wallenfels, 1961; Wallenfels et al., 1965). It was established that pullulanase specifically hydrolyzes α-(1→6) linkages in pullulan, yielding maltotriose as the repeating trimeric unit.
Pullulanase is a maltose-inducible starch-debranching enzyme originally characterized from Klebsiella pneumoniae. The secretion is dependent on products from at least eight secretion genes that are located on both sides of the pullulanase gene (pulA) in the chromosome of Klebsiella.
There is no documented traditional or ethnobotanical history of deliberate human use of pullulanase prior to the twentieth century. The enzyme is not a botanical ingredient, herb, or plant-derived supplement with a folk medicine tradition. Its history is entirely one of scientific discovery, industrial biotechnology, and food processing research, beginning in the early 1960s and expanding rapidly through the latter decades of the twentieth century as commercial starch processing demands grew.
Verhue and Hers (1966) and Brown and Brown (1966) studied liver and muscle branching enzymes by using pullulanase to split off chains formed by the branching enzyme. Pullulanase was used to determine the unit-chain profiles of Q-enzyme (potato branching enzyme) synthesized amylopectin from amylose. These studies established pullulanase as an essential analytical tool in carbohydrate biochemistry before its industrial applications were fully developed.
Pullulanase, an important debranching enzyme, has been widely utilised to hydrolyse the α-1,6 glucosidic linkages in starch, amylopectin, pullulan, and related oligosaccharides, which enables a complete and efficient conversion of the branched polysaccharides into small fermentable sugars during the saccharification process.
Debranching enzymes catalyse the hydrolysis of α-1,6-glucosidic bonds in amylopectin and/or glycogen and related polymers. The affinity of debranching enzymes for the α-1,6-bond distinguishes these enzymes from other amylases which have primary affinity for α-1,4-glucosidic linkages. This selectivity is of great biochemical importance: branch points in amylopectin occur on average every 20 to 25 D-glucose units, so that amylopectin contains 4% to 5% of α-1,6 glucosidic linkages.
Pullulanases consist of multiple distinct domains, including a catalytic domain belonging to glycoside hydrolase (GH) family 13 and carbohydrate-binding modules (CBM), including CBM41. Carbohydrate-binding module family 41 comprises modules of approximately 100 residues found primarily in bacterial pullulanases. The carbohydrate-binding modules serve to anchor the enzyme to its polysaccharide substrate, enhancing catalytic efficiency on insoluble or complex substrates.
The pullulanase produced with the non-genetically modified P. naganoensis (strain AE-PL) is a single polypeptide chain of 958 amino acids. Molecular masses among characterized pullulanases vary widely depending on domain architecture and species of origin.
Optimal reaction conditions vary by source organism. For cassava-derived pullulanase, optimal pH and temperature were at pH 6.0 and 50°C, and enzyme activity was enhanced by the addition of Ca²⁺ ions. Thermostable variants show much higher temperature optima: one thermophilic pullulanase from Bacillus sp. AN-7 showed an optimum temperature and pH for activity of 90°C and 6.0, with a half-life longer than one day at 80°C.
Pullulan is the most favourable substrate for cassava pullulanase, followed by β-limit dextrin. Additionally, maltooligosaccharides were identified as potential allosteric modulators of cassava pullulanase.
Gut bacterial amylase-mediated starch breakdown includes α-amylase for α-1,4 linkage, type I pullulanase for α-1,6 linkage, and amylopullulanases for both α-1,4 and α-1,6 linkages. This makes pullulanase-type activity a component of the normal intestinal microbial ecosystem in starch metabolism, distinct from the primary digestive enzymes secreted by the human pancreas.
Resistant starch, a concept central to several health-related applications of pullulanase, is defined analytically in terms of resistance to pullulanase activity: resistant starch (RS) was defined as "a small fraction of starch that was resistant to hydrolysis by exhaustive treatment with amylase and pullulanase in vitro." RS remains unhydrolyzed even after 120 minutes of incubation with α-amylase and pullulanase.
The primary application of pullulanase is in starch saccharification, and the most important industrial application of pullulanase is in the production of high-glucose (30% to 50% glucose; 30% to 40% maltose) or high-maltose (30% to 50% maltose; 6% to 10% glucose) syrups.
The industrial manufacturing of glucose involves two successive enzymatic steps: liquefaction, carried out after gelatinisation by the action of α-amylase; and saccharification, which results in further transformation of maltodextrins into glucose. During the saccharification process, pullulanase has been used to increase the final glucose concentration with a reduced amount of glucoamylase, thereby preventing the reversion reaction that involves resynthesis of saccharides from glucose molecules.
The use of pullulanase reduced the saccharification reaction time by up to 37.5%. In the case of maltose syrup production, the addition of pullulanase to β-amylase led to an almost total hydrolysis of the substrate (dextrins), which translated into a rise in the yield of whole sugars from 6.5 to 14%.
The low content of carbohydrates or low calories in beer is obtained by adding pullulanase, amyloglucosidase, or glucoamylase to the wort before or during fermentation. Pullulanases are also used in brewing to increase the amount of substrate for β-amylase and maximize the fermentability of the wort, and to decrease the amount and wort viscosity in the production of light beers.
During the conversion of starch into cyclodextrins (CDs), starch is liquefied by amylase and then cyclized by cyclodextrin glycosyltransferase (CGTase). The major problem associated with this conversion is the blockage of the action of CGTase by amylopectin, which was reported to be addressed with the use of pullulanase mutants. Cyclodextrins are used as hosts for important pharmaceuticals. They are potential industrial substrates for pharmaceuticals, cosmetics, agriculture, and in analytical chemistry, and are used in the manufacturing of cholesterol-free products.
Pullulanase can be used in baking as an "anti-staling" agent, that is to say as an additive to prevent bread from becoming stale during storage. This property is related to the enzyme's ability to modify the structure of branched starch components in baked goods, affecting retrogradation behavior.
Microbial pullulanases are used in a wide variety of industries: the starch processing industry (in the manufacturing of glucose, maltotriose, maltotetraose, panose, isopanose, and fructose syrups), production of high maltose corn syrup (for high-quality candy/ice cream and intravenous feeding), production of high-fructose corn syrup (for diabetic food formulation), production of cyclodextrins (for cholesterol-free products), brewing industry (for low-calorie beer), production of resistant starch, beverage industry (for clarification of fruit juices), baking industry (as an anti-staling agent), starch saccharification process, detergent industry (as an additive for formulations), bioethanol production, and preparation of dental plaque control agents with resistant starch.
Pullulanase can also be used in the preparation of low-calorie foods in which amylose is used as a substitute for fats.
One of the most studied health-relevant applications of pullulanase is its use in the enzymatic production of resistant starch (RS) with modified glycemic properties. Pullulanase debranches amylopectin, promoting retrogradation into crystalline structures that resist digestion.
A 2023 study published in a peer-reviewed journal examined the production of resistant starch in bulgur using pullulanase treatment combined with autoclaving-cooling cycles. RS contents of bulgurs obtained by enzyme application and autoclaving-cooling cycles were 3-fold higher than those of control bulgurs and reached a level of 9.47%. The glycemic index (GI) value of the bulgur produced from high-amylose wheat by pullulanase treatment and autoclaving-cooling cycles was quite low (52.11), classifying it as a low-GI food.
Resistant starch is defined as the fraction of starch that resists digestion in the small intestine of healthy humans but can be fermented in the large bowel. Because RS cannot be hydrolyzed by enzymes in the small intestine, when it reaches the large intestine, it serves as a fermentation substrate for gut microflora, promoting the growth of beneficial bacteria.
Evidence strength: The body of evidence on pullulanase-modified resistant starch and glycemic index is primarily based on in vitro measurement of starch digestibility and food composition studies. Human clinical trial data specifically attributing metabolic outcomes directly to pullulanase-treated food products (as opposed to resistant starch generally) are limited.
One human clinical study specifically examined the combined effect of resistant starch and pullulan (the polysaccharide substrate, not the enzyme pullulanase) on postprandial metabolic parameters. This study was a randomized, double-blind, crossover design in which fasted subjects (n = 20) consumed a low-fiber control breakfast or one of four breakfasts containing 25 g of fiber from soluble corn fiber (SCF) or resistant starch (RS), alone or in combination with pullulan. Visual analog scales assessed appetite, and blood samples were collected to measure glucose, insulin, ghrelin, and glucagon-like peptide-1 (GLP-1).
The fiber treatments did not influence satiety or energy intake compared to control. RS combined with pullulan significantly reduced glucose, insulin, and GLP-1, but neither soluble corn fiber treatment differed from control. The authors concluded that these fibers have little impact on satiety when provided as a mixed meal matched for calories and macronutrients. Additional research regarding the physiological effects of these novel fibers is needed to guide their use as functional ingredients in food products.
Important distinction: This study examined pullulan (the polysaccharide) combined with resistant starch — not the enzyme pullulanase itself as a dietary supplement. This distinction is critical. Pullulanase as an enzyme used in food processing acts on starch during manufacturing; it does not itself enter the diet in appreciable quantities in the same way as dietary fibers or polysaccharides. The health effects attributed to pullulanase-treated foods are primarily mediated through the altered starch structure the enzyme creates.
The downstream health effects of resistant starch produced using pullulanase enzyme treatment have been described in the scientific literature. The fermentation of RS by colonic microbiota in the large bowel produces short-chain fatty acids, which exert multiple metabolic effects on glucose regulation and homeostasis. Moreover, RS may influence glucose metabolism via bile acid modulation, independent of its fermentation.
Fermentation of resistant starch in rodent studies results in what appears to be a healthier gut, demonstrated by increased amounts of short-chain fatty acids, an apparent positive change in the microbiota, and increased gene expression for gene products involved in normal healthy proliferation and apoptosis of potential cancer cells. Additionally, consumption of resistant starch was associated with reduced abdominal fat and improved insulin sensitivity. Increased serum glucagon-like peptide 1 (GLP-1) likely plays a role in promoting these health benefits.
Evidence strength: Health effects of resistant starch on gut microbiota, short-chain fatty acid production, and glucose metabolism are supported by a substantial body of animal and some human research. However, the evidence linking pullulanase-enzyme treatment specifically (as distinct from the resulting RS product) to human health outcomes is indirect and limited. Most human studies are small, short-term, and of variable quality.
In scientific and regulatory contexts, pullulanase plays a standardized, established role as an analytical reagent. Resistant starch is defined as a type of starch that is resistant to hydrolysis by enzymatic digestion, and remains unhydrolyzed even after 120 minutes of incubation with α-amylase and pullulanase. This standardized in vitro test using pullulanase is the internationally recognized method by which resistant starch content of foods is classified and measured.
Debranching enzymes (including pullulanase) are required for both starch synthesis and degradation in plants. Research on plant pullulanases illuminates fundamental mechanisms of starch metabolism but does not directly translate to human dietary supplement applications.
Pullulanase, primarily as a food processing enzyme that modifies starch structure, is associated with the following body systems and health domains:
Pullulanase is not consumed as a dietary supplement in the conventional sense — i.e., it is not typically taken as a capsule, tablet, or powder by consumers seeking a health benefit. Rather, it functions as a processing aid or food enzyme applied at the manufacturing level. As such, dosages reported in the literature are industrial use levels rather than human supplement doses.
The food enzyme pullulanase is intended to be used in food manufacturing processes including processing of cereals and other grains for the production of baked products and cereal-based foods, among others. For brewery products, based on the maximum use level recommended for brewing processes and individual data from the EFSA Comprehensive European Food Consumption Database, dietary exposure to the food enzyme total organic solids (TOS) was estimated to be up to 0.053 mg TOS/kg body weight (bw) per day in European populations.
For broader food manufacturing processes, dietary exposure was calculated for eight food manufacturing processes and was estimated to be up to 0.075 mg TOS/kg body weight per day in European populations. These represent residual enzyme amounts remaining in final food products after processing, not intentional therapeutic doses.
In the clinical study that used pullulan as a dietary fiber supplement combined with resistant starch, subjects consumed 25 g of fiber from resistant starch alone or in combination with pullulan. This, however, pertains to the polysaccharide pullulan and not to the pullulanase enzyme itself.
All food enzymes currently on the EU market and intended to remain on that market, as well as all new food enzymes, shall be subjected to a safety evaluation by the European Food Safety Authority (EFSA) and approval via an EU Community list. Only food enzymes included in the Union list may be placed on the market as such and used in foods, in accordance with the specifications and conditions of use provided for in Regulation (EC) No 1332/2008 on food enzymes.
Multiple EFSA evaluations of pullulanase preparations from different microbial sources have been conducted. Based on compositional and biochemical data, the EFSA Panel concluded that the food enzyme pullulanase from P. naganoensis (strain AE-PL) does not give rise to safety concerns under the intended conditions of use. Based on the data provided, the EFSA Panel concluded that the food enzyme pullulanase from genetically modified Bacillus licheniformis (strain DP-Dzp39) does not raise safety concerns under the intended conditions of use.
In the European Union, both non-genetically modified (non-GM) and genetically modified (GM) strains of bacteria producing pullulanase have been subject to regulatory evaluation. GM strains derived from Bacillus subtilis, Bacillus licheniformis, and others have received EFSA opinions. One food enzyme is pullulanase produced with the genetically modified Bacillus subtilis strain NZYM-AK by Novozymes A/S (Denmark), intended for use in starch processing for the production of glucose syrups.
A specific and well-documented regulatory concern arises from the use of Klebsiella pneumoniae as a production organism for pullulanase. The food enzyme pullulanase (EC 3.2.1.41) produced by Amano Enzymes Inc. with the non-genetically modified Klebsiella pneumoniae strain AE-PUL originates from a known human pathogen. The food enzyme is free from viable cells of the production organism and its DNA.
EFSA's assessment of this preparation found that despite genotoxicity tests not indicating concern, the allergenicity profile was notable: a search for the homology of the amino acid sequence of the pullulanase to known allergens found matches with two food allergens. The Panel considered that a risk of allergic reactions upon dietary exposure to this food enzyme cannot be excluded.
Multiple EFSA evaluations provide a consistent picture across different pullulanase preparations. Genotoxicity tests did not indicate a safety concern. The systemic toxicity was assessed by means of a repeated-dose 90-day oral toxicity study in rats. The Panel identified a no-observed-adverse-effect level (NOAEL) of 124 mg TOS/kg bw per day, the highest dose tested, which when compared with the estimated dietary exposure, results in a margin of exposure of at least 1,653.
For pullulanase from Bacillus licheniformis (strain DP-Dzp39), the systemic toxicity was assessed by means of a repeated-dose 90-day oral toxicity study in rats. The Panel identified a no-observed-adverse-effect level at the highest dose of 500 mg TOS/kg bw per day, which compared to the estimated dietary exposure, results in a sufficiently high margin of exposure (at least 9,400).
The allergenicity profile of pullulanase varies by source organism. Pullulanase from P. naganoensis (strain AE-PL) is not described as a potential allergen and no food allergic reactions to this pullulanase have been reported; there is no evidence for potential allergenicity of this food enzyme.
In contrast, for the K. pneumoniae-derived preparation, the EFSA Panel considered that the results of the sequence homology search and the available literature indicate a risk of allergic reactions for salmon-allergic individuals upon dietary exposure to the pullulanase under assessment.
For Bacillus licheniformis-derived preparations evaluated under the Qualified Presumption of Safety (QPS) framework, the Panel considered that, under the intended conditions of use, the risk of allergic sensitisation and elicitation reactions by dietary exposure cannot be excluded, but the likelihood for this to occur is low.
Enzyme preparations used in food manufacturing can present inhalation risks during production. The general enzyme safety literature notes that occupational sensitization to enzyme proteins via the respiratory route is a recognized concern for workers in industries using concentrated enzyme preparations, distinct from dietary exposure risks. For food enzyme preparations generally, EFSA allergenicity assessments consider only dietary exposure to residual enzyme in finished food products, as noted in the evaluations of pullulanase from Bacillus licheniformis: the allergenicity assessment considered only the food enzyme and not carriers or other excipients that may be used in the final formulation.
Substances or products that may cause allergies or intolerances (including soybean meal) are used as raw materials in the media fed to the microorganisms. However, these proteins will be digested during the fermentation process and consumed by the microorganisms for cell growth, cell maintenance, and enzyme production. In addition, microbial biomass and fermentation solids will be removed. Therefore, potentially allergenic residues of these foods employed as protein sources are not expected to be present in the final food enzyme.
Several important limitations should be noted when reviewing the evidence base for pullulanase:
Health conditions that Pullulanase may help support.
Body systems that Pullulanase may help support.
Go back